PVI
LYRA

Pura Vida Investments’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Pura Vida Investments’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,265
Closed -$8.79M – 62
2024
Q1 		$8.79M Hold
28,265
– – 1.48% 14
2023
Q4 		$7.41M Hold
28,265
– – 1.13% 14
2023
Q3 		$5.53M Hold
28,265
– – 1.05% 35
2023
Q2 		$5.72M Sell
28,265
-11,674
-29% -$1.62M 0.76% 38
2023
Q1 		$4.01M Sell
39,939
-3,207
-7% -$397K 0.41% 54
2022
Q4 		$6.77M Sell
43,146
-7,060
-14% -$1.4M 0.35% 72
2022
Q3 		$12.6M Sell
50,206
-1,318
-3% -$390K 0.73% 38
2022
Q2 		$14.6M Buy
51,524
+41,113
+395% +$11.2M 0.85% 34
2022
Q1 		$2.09M Buy
10,411
+66
+0.6% +$14.5K 0.07% 157
2021
Q4 		$2.25M Sell
10,345
-323
-3% -$104K 0.08% 146
2021
Q3 		$4.87M Sell
10,668
-185
-2% -$70K 0.15% 148
2021
Q2 		$4.36M Buy
+10,853
New +$4.94M 0.14% 129
2020
Q4 		– Sell
-4,534
Closed -$2.54M – 209
2020
Q3 		$2.54M Buy
4,534
+574
+14% +$357K 0.13% 112
2020
Q2 		$2.25M Buy
+3,960
New +$2.89M 0.22% 84

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pura Vida Investments's LYRA Position: Q2 2024 in Review

Pura Vida Investments sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2024, closing a stake of 28,265 shares — an estimated $8.79M sold.

Pura Vida Investments first reported a position in LYRA in Q2 2020 and held it in 14 quarters. The position peaked at $14.6M in Q2 2022. 51 funds tracked by Wall St. Rank hold LYRA as of Q2 2024.

  • Pura Vida Investments reported no remaining LYRA THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 28,265 LYRA THERAPEUTICS INC shares in Q2 2024, an estimated $8.79M.
  • Pura Vida Investments first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 14 quarters.
  • Pura Vida Investments's LYRA THERAPEUTICS INC position peaked at $14.6M in Q2 2022.
  • 51 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.